Ftaxilide,
19368-18-4,
Histanorm,
2',6'-Dimethylphthalanilic acid,
Ftaxilide [INN:DCF],
Ftaxilidum [INN-Latin],
Ftaxilida [INN-Spanish],
Phthalic 2,6-dimethylanilide,
UNII-7Z71845H3F,
MP 12,
NSC 16112,
Phthalanilic acid, 2',6'-dimethyl-,
BRN 2659992,
2-[(2,6-dimethylphenyl)carbamoyl]benzoic acid,
MP-12-P,
2-(((2,6-Dimethylphenyl)amino)carbonyl)benzoic acid,
MFCD00029943,
7Z71845H3F,
NCGC00160683-01,
2-(2,6-Dimethylphenylcarbamoyl)benzoic acid,
DSSTox_CID_26300,
DSSTox_RID_81525,
DSSTox_GSID_46300,
Ftaxilidum,
Ftaxilida,
CAS-19368-18-4,
SR-01000253137,
2-{[(2,6-dimethylphenyl)amino]carbonyl}benzoic acid,
Ftaxilid,
AC1Q2NBF,
AC1L2H0J,
Oprea1_160752,
MLS000876772,
SCHEMBL1170617,
ZINC1490,
Phthalanilic acid,6'-dimethyl-,
Benzoic acid, 2-(((2,6-dimethylphenyl)amino)carbonyl)-,
CHEMBL1308252,
DTXSID5046300,
HMS2981J15,
HMS3264M09,
Pharmakon1600-01504523,
HY-B1040,
NSC16112,
Tox21_111986,
NSC-16112,
NSC758893,
STK267964,
AKOS001678089,
Tox21_111986_1,
CCG-213931,
CS-4559,
MCULE-5351780489,
N-(2,6-XYLYL)PHTHALAMIC ACID,
NSC-758893,
ACM19368184,
NCGC00160683-03,
AK546602,
SMR000673583,
SBI-0207060.P001,
LS-109102,
ST50552581,
2-[(2,6-dimethylanilino)carbonyl]benzoic acid,
AB00865150_06,
2-[N-(2,6-dimethylphenyl)carbamoyl]benzoic acid,
AK-918/41204433,
2-(2,6-Dimethylphenylcarbamoyl)benzoic acid, 97%,
SR-01000253137-1,
SR-01000253137-3,
BRD-K05724540-001-04-4,
Benzoic acid, 2-(((2,6-dimethylphenyl)amino)carbonyl)- (9CI),
Ftaxilide [DCF:INN],
D09WFL,
TSI-GSD-223,
MP-12,
CID71895,
C16-H15-N-O3,
ZH548-M12,
Rift Valley fever vaccine, USAMRIID,
4-12-00-02527 (Beilstein Handbook Reference),